The aim of this study was to determine the proportion of genitourinary (GU) medicine patients attending a mixed urban/rural clinic who would welcome patient-delivered partner therapy (PDPT) as a partner management option. Five hundred patients completed the questionnaire. Acceptability of traditional partner referral was 87% (435), partner referral with infection specific guidance was 82% (411) and PDPT was 81% (405). Significantly fewer patients, 71% (354) would find a partner home sampling kit acceptable and provider referral was the least popular option at 23% (117). PDPT is not used in the UK mainly due to concerns of health professionals regarding the legal status of PDPT and the lack of UK evidence. The outcome of the Medical Research Council randomized controlled trial on accelerated partner therapy (which fits in with General Medical Council advice on remote prescribing) is eagerly awaited as professionals would welcome evidence-based guidance and our study suggests that patients are willing to consider this form of partner management as an additional treatment option.

Patients with symptomatic azole-resistant Candida albicans or non-albicans candida are difficult to manage. Treatment is largely anecdotal due to the relatively small number of patients. We present six case reports which highlight our own observation in clinical practice including four patients who were treated successfully with topical amphotericin B/flucytosine vaginal gel for 14 days (Stoke-on-Trent formula).

Local service quality indicators (SQIs) both for genitourinary medicine and HIV were drafted following patient and public involvement in 2009. At that time there were few published data to help in setting some of the original SQIs. Our clinical performance was audited against these SQIs in 2009 and subsequently re-audited in 2010 and 2011. The SQIs were revised based upon the results of the three audits. This paper attempts to explain the revisions based upon the audits. Commissioners are currently working with service providers around the country to develop HIV clinical outcome indicators that link payment to performance. It is vital to ensure that clinical outcome indicators are set correctly so that they are challenging but still achievable. We hope other services may wish to audit performance against our revised measures. If such data were to be pooled this could provide evidence for more robust benchmarking.

A re-audit of the management of gonorrhoea was undertaken in 2014. Six out of nine auditable outcomes were met in the second audit (2014) compared with three out of eight in the first audit (2012). The new measures that were introduced following the original audit may have helped to improve outcomes. However, electronic patient records were introduced in December 2012. Documentation was much improved with the use of patient record templates and this has contributed considerably to the improved outcomes.